Given the comprehensive cancer-related functions of ATAD2, disrupting the ATAD2-acetyl-lysine interactions has emerged as a potential therapeutic target in cancer, and a lot of pioneering efforts have been made to develop ATAD2 inhibitors from both pharmaceutical and academic settings. Here, ATAD2 is linked to cancer.